# Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer

> **NCT00004917** · PHASE3 · COMPLETED · sponsor: **Radiation Therapy Oncology Group**

## Conditions studied

- Anemia
- Head and Neck Cancer

## Interventions

- **BIOLOGICAL:** epoetin alfa
- **DRUG:** cisplatin
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00004917
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-06
- **Primary completion:** 2007-11
- **Final completion:** 2016-12
- **Target enrollment:** — (—)
- **Last updated:** 2020-10-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004917, "Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00004917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
